Enzo Biochem, Inc.
Enzo Biochem, Inc. ENZ Peers
See (ENZ) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ENZ | $0.31 | -17.77% | 16.4M | -2.24 | -$0.14 | +31.87% |
| DHR-PB | $1,261.26 | -0.78% | 916.8B | 146.01 | $8.64 | +0.60% |
| TMO | $408.28 | -0.93% | 154.1B | 23.93 | $17.06 | +0.40% |
| DHR | $198.80 | -1.32% | 142.3B | 38.45 | $5.17 | +0.60% |
| IDXX | $531.32 | +0.67% | 42.7B | 49.15 | $10.81 | N/A |
| A | $119.17 | -0.21% | 33.8B | 29.33 | $4.06 | +0.82% |
| IQV | $157.47 | -0.44% | 27.2B | 21.47 | $7.33 | N/A |
| MTD | $1,184.54 | -0.73% | 24.6B | 29.56 | $40.04 | N/A |
| NTRA | $167.96 | -0.12% | 22.9B | -113.49 | -$1.48 | N/A |
| WAT | $352.41 | -0.70% | 21B | 31.96 | $11.03 | N/A |
Stock Comparison
ENZ vs DHR-PB Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, ENZ is priced at $0.31, while DHR-PB trades at $1,261.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, ENZ's ROE is -0.39%, compared to DHR-PB's ROE of +0.07%. Regarding short-term risk, ENZ is more volatile compared to DHR-PB. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs TMO Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, TMO has a market cap of 154.1B. Regarding current trading prices, ENZ is priced at $0.31, while TMO trades at $408.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas TMO's P/E ratio is 23.93. In terms of profitability, ENZ's ROE is -0.39%, compared to TMO's ROE of +0.13%. Regarding short-term risk, ENZ is more volatile compared to TMO. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs DHR Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, DHR has a market cap of 142.3B. Regarding current trading prices, ENZ is priced at $0.31, while DHR trades at $198.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas DHR's P/E ratio is 38.45. In terms of profitability, ENZ's ROE is -0.39%, compared to DHR's ROE of +0.07%. Regarding short-term risk, ENZ is more volatile compared to DHR. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs IDXX Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, IDXX has a market cap of 42.7B. Regarding current trading prices, ENZ is priced at $0.31, while IDXX trades at $531.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas IDXX's P/E ratio is 49.15. In terms of profitability, ENZ's ROE is -0.39%, compared to IDXX's ROE of +0.57%. Regarding short-term risk, ENZ is more volatile compared to IDXX. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs A Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, A has a market cap of 33.8B. Regarding current trading prices, ENZ is priced at $0.31, while A trades at $119.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas A's P/E ratio is 29.33. In terms of profitability, ENZ's ROE is -0.39%, compared to A's ROE of +0.19%. Regarding short-term risk, ENZ is more volatile compared to A. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs IQV Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, IQV has a market cap of 27.2B. Regarding current trading prices, ENZ is priced at $0.31, while IQV trades at $157.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas IQV's P/E ratio is 21.47. In terms of profitability, ENZ's ROE is -0.39%, compared to IQV's ROE of +0.21%. Regarding short-term risk, ENZ is more volatile compared to IQV. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs MTD Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, MTD has a market cap of 24.6B. Regarding current trading prices, ENZ is priced at $0.31, while MTD trades at $1,184.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas MTD's P/E ratio is 29.56. In terms of profitability, ENZ's ROE is -0.39%, compared to MTD's ROE of +1.21%. Regarding short-term risk, ENZ is more volatile compared to MTD. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs NTRA Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, NTRA has a market cap of 22.9B. Regarding current trading prices, ENZ is priced at $0.31, while NTRA trades at $167.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas NTRA's P/E ratio is -113.49. In terms of profitability, ENZ's ROE is -0.39%, compared to NTRA's ROE of -0.18%. Regarding short-term risk, ENZ is more volatile compared to NTRA. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs WAT Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, WAT has a market cap of 21B. Regarding current trading prices, ENZ is priced at $0.31, while WAT trades at $352.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas WAT's P/E ratio is 31.96. In terms of profitability, ENZ's ROE is -0.39%, compared to WAT's ROE of +0.39%. Regarding short-term risk, ENZ is more volatile compared to WAT. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs DGX Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, DGX has a market cap of 19.9B. Regarding current trading prices, ENZ is priced at $0.31, while DGX trades at $177.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas DGX's P/E ratio is 22.48. In terms of profitability, ENZ's ROE is -0.39%, compared to DGX's ROE of +0.13%. Regarding short-term risk, ENZ is more volatile compared to DGX. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs ILMN Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, ILMN has a market cap of 15B. Regarding current trading prices, ENZ is priced at $0.31, while ILMN trades at $94.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas ILMN's P/E ratio is -15.59. In terms of profitability, ENZ's ROE is -0.39%, compared to ILMN's ROE of -0.46%. Regarding short-term risk, ENZ is more volatile compared to ILMN. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs PKI Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, PKI has a market cap of 14.5B. Regarding current trading prices, ENZ is priced at $0.31, while PKI trades at $115.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas PKI's P/E ratio is 41.45. In terms of profitability, ENZ's ROE is -0.39%, compared to PKI's ROE of +0.04%. Regarding short-term risk, ENZ is more volatile compared to PKI. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs ICLR Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, ICLR has a market cap of 11.7B. Regarding current trading prices, ENZ is priced at $0.31, while ICLR trades at $144.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas ICLR's P/E ratio is 15.75. In terms of profitability, ENZ's ROE is -0.39%, compared to ICLR's ROE of +0.08%. Regarding short-term risk, ENZ is more volatile compared to ICLR. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs RVTY Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, RVTY has a market cap of 11.5B. Regarding current trading prices, ENZ is priced at $0.31, while RVTY trades at $97.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas RVTY's P/E ratio is 40.41. In terms of profitability, ENZ's ROE is -0.39%, compared to RVTY's ROE of +0.04%. Regarding short-term risk, ENZ is more volatile compared to RVTY. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs TEM Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, TEM has a market cap of 11.2B. Regarding current trading prices, ENZ is priced at $0.31, while TEM trades at $66.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas TEM's P/E ratio is -12.89. In terms of profitability, ENZ's ROE is -0.39%, compared to TEM's ROE of -5.31%. Regarding short-term risk, ENZ is more volatile compared to TEM. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs QGEN Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, QGEN has a market cap of 10.3B. Regarding current trading prices, ENZ is priced at $0.31, while QGEN trades at $47.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas QGEN's P/E ratio is 111.09. In terms of profitability, ENZ's ROE is -0.39%, compared to QGEN's ROE of +0.03%. Regarding short-term risk, ENZ is more volatile compared to QGEN. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs EXAS Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, EXAS has a market cap of 10.1B. Regarding current trading prices, ENZ is priced at $0.31, while EXAS trades at $53.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas EXAS's P/E ratio is -9.70. In terms of profitability, ENZ's ROE is -0.39%, compared to EXAS's ROE of -0.36%. Regarding short-term risk, ENZ is more volatile compared to EXAS. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs MEDP Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, MEDP has a market cap of 8.9B. Regarding current trading prices, ENZ is priced at $0.31, while MEDP trades at $310.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas MEDP's P/E ratio is 23.72. In terms of profitability, ENZ's ROE is -0.39%, compared to MEDP's ROE of +0.54%. Regarding short-term risk, ENZ is more volatile compared to MEDP. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs CRL Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, CRL has a market cap of 7.4B. Regarding current trading prices, ENZ is priced at $0.31, while CRL trades at $150.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas CRL's P/E ratio is -250.05. In terms of profitability, ENZ's ROE is -0.39%, compared to CRL's ROE of -0.01%. Regarding short-term risk, ENZ is more volatile compared to CRL. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs GH Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, GH has a market cap of 6.3B. Regarding current trading prices, ENZ is priced at $0.31, while GH trades at $50.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas GH's P/E ratio is -15.00. In terms of profitability, ENZ's ROE is -0.39%, compared to GH's ROE of +3.69%. Regarding short-term risk, ENZ is more volatile compared to GH. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs SYNH Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, SYNH has a market cap of 4.5B. Regarding current trading prices, ENZ is priced at $0.31, while SYNH trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas SYNH's P/E ratio is 61.40. In terms of profitability, ENZ's ROE is -0.39%, compared to SYNH's ROE of +0.08%. Regarding short-term risk, ENZ is more volatile compared to SYNH. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs RDNT Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, RDNT has a market cap of 4.3B. Regarding current trading prices, ENZ is priced at $0.31, while RDNT trades at $57.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas RDNT's P/E ratio is -132.84. In terms of profitability, ENZ's ROE is -0.39%, compared to RDNT's ROE of +0.03%. Regarding short-term risk, ENZ is more volatile compared to RDNT. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs OLK Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, OLK has a market cap of 3.2B. Regarding current trading prices, ENZ is priced at $0.31, while OLK trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas OLK's P/E ratio is -96.59. In terms of profitability, ENZ's ROE is -0.39%, compared to OLK's ROE of -0.05%. Regarding short-term risk, ENZ is more volatile compared to OLK. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs SHC Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, SHC has a market cap of 3.2B. Regarding current trading prices, ENZ is priced at $0.31, while SHC trades at $11.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas SHC's P/E ratio is 125.78. In terms of profitability, ENZ's ROE is -0.39%, compared to SHC's ROE of +0.06%. Regarding short-term risk, ENZ is more volatile compared to SHC. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs TWST Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, TWST has a market cap of 2.2B. Regarding current trading prices, ENZ is priced at $0.31, while TWST trades at $35.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas TWST's P/E ratio is -11.06. In terms of profitability, ENZ's ROE is -0.39%, compared to TWST's ROE of -0.41%. Regarding short-term risk, ENZ is more volatile compared to TWST. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs GRAL Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, GRAL has a market cap of 1.7B. Regarding current trading prices, ENZ is priced at $0.31, while GRAL trades at $48.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas GRAL's P/E ratio is -0.81. In terms of profitability, ENZ's ROE is -0.39%, compared to GRAL's ROE of -0.75%. Regarding short-term risk, ENZ is more volatile compared to GRAL. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs VIVO Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, VIVO has a market cap of 1.5B. Regarding current trading prices, ENZ is priced at $0.31, while VIVO trades at $33.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas VIVO's P/E ratio is 21.09. In terms of profitability, ENZ's ROE is -0.39%, compared to VIVO's ROE of +0.12%. Regarding short-term risk, ENZ is more volatile compared to VIVO. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs CDNA Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, CDNA has a market cap of 1.1B. Regarding current trading prices, ENZ is priced at $0.31, while CDNA trades at $19.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas CDNA's P/E ratio is 17.17. In terms of profitability, ENZ's ROE is -0.39%, compared to CDNA's ROE of +0.18%. Regarding short-term risk, ENZ is more volatile compared to CDNA. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs OPK Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, OPK has a market cap of 1B. Regarding current trading prices, ENZ is priced at $0.31, while OPK trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas OPK's P/E ratio is -22.00. In terms of profitability, ENZ's ROE is -0.39%, compared to OPK's ROE of -0.03%. Regarding short-term risk, ENZ is more volatile compared to OPK. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs NEOG Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, NEOG has a market cap of 1B. Regarding current trading prices, ENZ is priced at $0.31, while NEOG trades at $4.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas NEOG's P/E ratio is -2.12. In terms of profitability, ENZ's ROE is -0.39%, compared to NEOG's ROE of -0.17%. Regarding short-term risk, ENZ is more volatile compared to NEOG. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs FLGT Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, FLGT has a market cap of 599.1M. Regarding current trading prices, ENZ is priced at $0.31, while FLGT trades at $19.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas FLGT's P/E ratio is -14.80. In terms of profitability, ENZ's ROE is -0.39%, compared to FLGT's ROE of -0.04%. Regarding short-term risk, ENZ is more volatile compared to FLGT. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs CSTL Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, CSTL has a market cap of 587.6M. Regarding current trading prices, ENZ is priced at $0.31, while CSTL trades at $20.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas CSTL's P/E ratio is -107.11. In terms of profitability, ENZ's ROE is -0.39%, compared to CSTL's ROE of -0.01%. Regarding short-term risk, ENZ is more volatile compared to CSTL. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs PSNL Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, PSNL has a market cap of 581.2M. Regarding current trading prices, ENZ is priced at $0.31, while PSNL trades at $6.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas PSNL's P/E ratio is -5.10. In terms of profitability, ENZ's ROE is -0.39%, compared to PSNL's ROE of -0.49%. Regarding short-term risk, ENZ is more volatile compared to PSNL. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs GRALV Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, GRALV has a market cap of 579.4M. Regarding current trading prices, ENZ is priced at $0.31, while GRALV trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas GRALV's P/E ratio is N/A. In terms of profitability, ENZ's ROE is -0.39%, compared to GRALV's ROE of N/A. Regarding short-term risk, ENZ is more volatile compared to GRALV. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs MYGN Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, MYGN has a market cap of 483.9M. Regarding current trading prices, ENZ is priced at $0.31, while MYGN trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas MYGN's P/E ratio is -4.69. In terms of profitability, ENZ's ROE is -0.39%, compared to MYGN's ROE of -0.14%. Regarding short-term risk, ENZ is more volatile compared to MYGN. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs LAB Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, LAB has a market cap of 452M. Regarding current trading prices, ENZ is priced at $0.31, while LAB trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas LAB's P/E ratio is -3.72. In terms of profitability, ENZ's ROE is -0.39%, compared to LAB's ROE of -0.28%. Regarding short-term risk, ENZ is more volatile compared to LAB. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs CO Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, CO has a market cap of 400.1M. Regarding current trading prices, ENZ is priced at $0.31, while CO trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas CO's P/E ratio is 5.06. In terms of profitability, ENZ's ROE is -0.39%, compared to CO's ROE of +0.11%. Regarding short-term risk, ENZ is less volatile compared to CO. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.
ENZ vs FLDM Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, FLDM has a market cap of 294.2M. Regarding current trading prices, ENZ is priced at $0.31, while FLDM trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas FLDM's P/E ratio is -4.74. In terms of profitability, ENZ's ROE is -0.39%, compared to FLDM's ROE of -0.28%. Regarding short-term risk, ENZ is more volatile compared to FLDM. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs STIM Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, STIM has a market cap of 232.3M. Regarding current trading prices, ENZ is priced at $0.31, while STIM trades at $3.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas STIM's P/E ratio is -2.67. In terms of profitability, ENZ's ROE is -0.39%, compared to STIM's ROE of -2.09%. Regarding short-term risk, ENZ is more volatile compared to STIM. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs NEO Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, NEO has a market cap of 184.8M. Regarding current trading prices, ENZ is priced at $0.31, while NEO trades at $7.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas NEO's P/E ratio is -11.77. In terms of profitability, ENZ's ROE is -0.39%, compared to NEO's ROE of -0.09%. Regarding short-term risk, ENZ is more volatile compared to NEO. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs ACRS Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, ACRS has a market cap of 156.5M. Regarding current trading prices, ENZ is priced at $0.31, while ACRS trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas ACRS's P/E ratio is -0.91. In terms of profitability, ENZ's ROE is -0.39%, compared to ACRS's ROE of -0.92%. Regarding short-term risk, ENZ is more volatile compared to ACRS. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs XGN Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, XGN has a market cap of 153M. Regarding current trading prices, ENZ is priced at $0.31, while XGN trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas XGN's P/E ratio is -8.33. In terms of profitability, ENZ's ROE is -0.39%, compared to XGN's ROE of -1.34%. Regarding short-term risk, ENZ is more volatile compared to XGN. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs SERA Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, SERA has a market cap of 150.1M. Regarding current trading prices, ENZ is priced at $0.31, while SERA trades at $4.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas SERA's P/E ratio is -4.35. In terms of profitability, ENZ's ROE is -0.39%, compared to SERA's ROE of -0.51%. Regarding short-term risk, ENZ is less volatile compared to SERA. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.
ENZ vs PRENW Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, PRENW has a market cap of 135.4M. Regarding current trading prices, ENZ is priced at $0.31, while PRENW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas PRENW's P/E ratio is N/A. In terms of profitability, ENZ's ROE is -0.39%, compared to PRENW's ROE of -0.28%. Regarding short-term risk, ENZ is less volatile compared to PRENW. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.
ENZ vs GTH Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, GTH has a market cap of 127.3M. Regarding current trading prices, ENZ is priced at $0.31, while GTH trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas GTH's P/E ratio is -1.11. In terms of profitability, ENZ's ROE is -0.39%, compared to GTH's ROE of -1.01%. Regarding short-term risk, ENZ is more volatile compared to GTH. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs MDXH Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, MDXH has a market cap of 113.8M. Regarding current trading prices, ENZ is priced at $0.31, while MDXH trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas MDXH's P/E ratio is -2.21. In terms of profitability, ENZ's ROE is -0.39%, compared to MDXH's ROE of -5.35%. Regarding short-term risk, ENZ is more volatile compared to MDXH. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs GENE Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, GENE has a market cap of 111.2M. Regarding current trading prices, ENZ is priced at $0.31, while GENE trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas GENE's P/E ratio is -38.25. In terms of profitability, ENZ's ROE is -0.39%, compared to GENE's ROE of -3.62%. Regarding short-term risk, ENZ is more volatile compared to GENE. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs PRE Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, PRE has a market cap of 110.7M. Regarding current trading prices, ENZ is priced at $0.31, while PRE trades at $8.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas PRE's P/E ratio is -2.23. In terms of profitability, ENZ's ROE is -0.39%, compared to PRE's ROE of -0.28%. Regarding short-term risk, ENZ is more volatile compared to PRE. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs ATLN Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, ATLN has a market cap of 103.9M. Regarding current trading prices, ENZ is priced at $0.31, while ATLN trades at $1.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas ATLN's P/E ratio is -0.48. In terms of profitability, ENZ's ROE is -0.39%, compared to ATLN's ROE of -19.68%. Regarding short-term risk, ENZ is less volatile compared to ATLN. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.
ENZ vs VNRX Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, VNRX has a market cap of 85.5M. Regarding current trading prices, ENZ is priced at $0.31, while VNRX trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas VNRX's P/E ratio is -3.07. In terms of profitability, ENZ's ROE is -0.39%, compared to VNRX's ROE of +1.08%. Regarding short-term risk, ENZ is more volatile compared to VNRX. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs NOTV Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, NOTV has a market cap of 58.4M. Regarding current trading prices, ENZ is priced at $0.31, while NOTV trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas NOTV's P/E ratio is -0.54. In terms of profitability, ENZ's ROE is -0.39%, compared to NOTV's ROE of -0.51%. Regarding short-term risk, ENZ is more volatile compared to NOTV. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs OPGN Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, OPGN has a market cap of 46.3M. Regarding current trading prices, ENZ is priced at $0.31, while OPGN trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas OPGN's P/E ratio is -0.30. In terms of profitability, ENZ's ROE is -0.39%, compared to OPGN's ROE of +1.20%. Regarding short-term risk, ENZ is more volatile compared to OPGN. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs BDSX Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, BDSX has a market cap of 36.7M. Regarding current trading prices, ENZ is priced at $0.31, while BDSX trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas BDSX's P/E ratio is -0.93. In terms of profitability, ENZ's ROE is -0.39%, compared to BDSX's ROE of -1.68%. Regarding short-term risk, ENZ is more volatile compared to BDSX. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs DRIO Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, DRIO has a market cap of 29.8M. Regarding current trading prices, ENZ is priced at $0.31, while DRIO trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas DRIO's P/E ratio is -1.22. In terms of profitability, ENZ's ROE is -0.39%, compared to DRIO's ROE of -0.17%. Regarding short-term risk, ENZ is more volatile compared to DRIO. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs STRRP Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, STRRP has a market cap of 28.7M. Regarding current trading prices, ENZ is priced at $0.31, while STRRP trades at $8.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas STRRP's P/E ratio is -4.48. In terms of profitability, ENZ's ROE is -0.39%, compared to STRRP's ROE of -0.24%. Regarding short-term risk, ENZ is more volatile compared to STRRP. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs AKU Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, AKU has a market cap of 26.3M. Regarding current trading prices, ENZ is priced at $0.31, while AKU trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas AKU's P/E ratio is -0.13. In terms of profitability, ENZ's ROE is -0.39%, compared to AKU's ROE of -5.32%. Regarding short-term risk, ENZ is more volatile compared to AKU. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs CEMI Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, CEMI has a market cap of 16.7M. Regarding current trading prices, ENZ is priced at $0.31, while CEMI trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas CEMI's P/E ratio is -0.63. In terms of profitability, ENZ's ROE is -0.39%, compared to CEMI's ROE of -0.89%. Regarding short-term risk, ENZ is more volatile compared to CEMI. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs PRPO Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, PRPO has a market cap of 16M. Regarding current trading prices, ENZ is priced at $0.31, while PRPO trades at $10.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas PRPO's P/E ratio is -5.15. In terms of profitability, ENZ's ROE is -0.39%, compared to PRPO's ROE of -0.26%. Regarding short-term risk, ENZ is more volatile compared to PRPO. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs PMD Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, PMD has a market cap of 15.7M. Regarding current trading prices, ENZ is priced at $0.31, while PMD trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas PMD's P/E ratio is -5.24. In terms of profitability, ENZ's ROE is -0.39%, compared to PMD's ROE of -0.33%. Regarding short-term risk, ENZ is more volatile compared to PMD. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs ADVB Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, ADVB has a market cap of 15.4M. Regarding current trading prices, ENZ is priced at $0.31, while ADVB trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas ADVB's P/E ratio is -4.44. In terms of profitability, ENZ's ROE is -0.39%, compared to ADVB's ROE of -1.86%. Regarding short-term risk, ENZ is more volatile compared to ADVB. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs ME Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, ME has a market cap of 13.3M. Regarding current trading prices, ENZ is priced at $0.31, while ME trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas ME's P/E ratio is -0.03. In terms of profitability, ENZ's ROE is -0.39%, compared to ME's ROE of -3.10%. Regarding short-term risk, ENZ is more volatile compared to ME. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs TRIB Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, TRIB has a market cap of 12.1M. Regarding current trading prices, ENZ is priced at $0.31, while TRIB trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas TRIB's P/E ratio is -0.36. In terms of profitability, ENZ's ROE is -0.39%, compared to TRIB's ROE of +1.12%. Regarding short-term risk, ENZ is more volatile compared to TRIB. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs BNGO Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, BNGO has a market cap of 11.1M. Regarding current trading prices, ENZ is priced at $0.31, while BNGO trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas BNGO's P/E ratio is -0.06. In terms of profitability, ENZ's ROE is -0.39%, compared to BNGO's ROE of -1.57%. Regarding short-term risk, ENZ is more volatile compared to BNGO. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs INBS Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, INBS has a market cap of 10.6M. Regarding current trading prices, ENZ is priced at $0.31, while INBS trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas INBS's P/E ratio is -1.15. In terms of profitability, ENZ's ROE is -0.39%, compared to INBS's ROE of -1.72%. Regarding short-term risk, ENZ is more volatile compared to INBS. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs BIAFW Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, BIAFW has a market cap of 10.6M. Regarding current trading prices, ENZ is priced at $0.31, while BIAFW trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas BIAFW's P/E ratio is N/A. In terms of profitability, ENZ's ROE is -0.39%, compared to BIAFW's ROE of -3.68%. Regarding short-term risk, ENZ is more volatile compared to BIAFW. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs CNTG Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, CNTG has a market cap of 9.4M. Regarding current trading prices, ENZ is priced at $0.31, while CNTG trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas CNTG's P/E ratio is -0.23. In terms of profitability, ENZ's ROE is -0.39%, compared to CNTG's ROE of +3.98%. Regarding short-term risk, ENZ is less volatile compared to CNTG. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.
ENZ vs BIAF Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, BIAF has a market cap of 8.4M. Regarding current trading prices, ENZ is priced at $0.31, while BIAF trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas BIAF's P/E ratio is -0.42. In terms of profitability, ENZ's ROE is -0.39%, compared to BIAF's ROE of -3.68%. Regarding short-term risk, ENZ is less volatile compared to BIAF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.
ENZ vs STRR Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, STRR has a market cap of 6.5M. Regarding current trading prices, ENZ is priced at $0.31, while STRR trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas STRR's P/E ratio is -0.68. In terms of profitability, ENZ's ROE is -0.39%, compared to STRR's ROE of -0.24%. Regarding short-term risk, ENZ is more volatile compared to STRR. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs NVTA Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, NVTA has a market cap of 5.4M. Regarding current trading prices, ENZ is priced at $0.31, while NVTA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas NVTA's P/E ratio is -0.00. In terms of profitability, ENZ's ROE is -0.39%, compared to NVTA's ROE of -2.02%. Regarding short-term risk, ENZ is less volatile compared to NVTA. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.
ENZ vs MYNZ Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, MYNZ has a market cap of 5.2M. Regarding current trading prices, ENZ is priced at $0.31, while MYNZ trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas MYNZ's P/E ratio is -0.07. In terms of profitability, ENZ's ROE is -0.39%, compared to MYNZ's ROE of -22.70%. Regarding short-term risk, ENZ is more volatile compared to MYNZ. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs LMDX Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, LMDX has a market cap of 5.1M. Regarding current trading prices, ENZ is priced at $0.31, while LMDX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas LMDX's P/E ratio is -0.01. In terms of profitability, ENZ's ROE is -0.39%, compared to LMDX's ROE of -15.58%. Regarding short-term risk, ENZ is less volatile compared to LMDX. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.
ENZ vs LMDXW Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, LMDXW has a market cap of 5.1M. Regarding current trading prices, ENZ is priced at $0.31, while LMDXW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas LMDXW's P/E ratio is N/A. In terms of profitability, ENZ's ROE is -0.39%, compared to LMDXW's ROE of -15.58%. Regarding short-term risk, ENZ is less volatile compared to LMDXW. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.
ENZ vs BGLC Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, BGLC has a market cap of 5M. Regarding current trading prices, ENZ is priced at $0.31, while BGLC trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas BGLC's P/E ratio is -2.33. In terms of profitability, ENZ's ROE is -0.39%, compared to BGLC's ROE of -0.24%. Regarding short-term risk, ENZ is more volatile compared to BGLC. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs CHEK Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, CHEK has a market cap of 4.5M. Regarding current trading prices, ENZ is priced at $0.31, while CHEK trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas CHEK's P/E ratio is -0.36. In terms of profitability, ENZ's ROE is -0.39%, compared to CHEK's ROE of -0.52%. Regarding short-term risk, ENZ is more volatile compared to CHEK. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs TTOO Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, TTOO has a market cap of 4M. Regarding current trading prices, ENZ is priced at $0.31, while TTOO trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas TTOO's P/E ratio is -4.75. In terms of profitability, ENZ's ROE is -0.39%, compared to TTOO's ROE of +2.06%. Regarding short-term risk, ENZ is more volatile compared to TTOO. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs BNR Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, BNR has a market cap of 3.3M. Regarding current trading prices, ENZ is priced at $0.31, while BNR trades at $3.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas BNR's P/E ratio is -0.95. In terms of profitability, ENZ's ROE is -0.39%, compared to BNR's ROE of -0.39%. Regarding short-term risk, ENZ is more volatile compared to BNR. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs DMTK Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, DMTK has a market cap of 3.3M. Regarding current trading prices, ENZ is priced at $0.31, while DMTK trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas DMTK's P/E ratio is -0.04. In terms of profitability, ENZ's ROE is -0.39%, compared to DMTK's ROE of -0.80%. Regarding short-term risk, ENZ is more volatile compared to DMTK. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs AWH Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, AWH has a market cap of 2.9M. Regarding current trading prices, ENZ is priced at $0.31, while AWH trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas AWH's P/E ratio is -0.09. In terms of profitability, ENZ's ROE is -0.39%, compared to AWH's ROE of +4.66%. Regarding short-term risk, ENZ is more volatile compared to AWH. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs NDRA Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, NDRA has a market cap of 2.7M. Regarding current trading prices, ENZ is priced at $0.31, while NDRA trades at $3.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas NDRA's P/E ratio is 0.01. In terms of profitability, ENZ's ROE is -0.39%, compared to NDRA's ROE of -1.96%. Regarding short-term risk, ENZ is more volatile compared to NDRA. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs SQL Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, SQL has a market cap of 2.5M. Regarding current trading prices, ENZ is priced at $0.31, while SQL trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas SQL's P/E ratio is -0.40. In terms of profitability, ENZ's ROE is -0.39%, compared to SQL's ROE of +10.89%. Regarding short-term risk, ENZ is more volatile compared to SQL. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs APDN Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, APDN has a market cap of 2.5M. Regarding current trading prices, ENZ is priced at $0.31, while APDN trades at $4.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas APDN's P/E ratio is N/A. In terms of profitability, ENZ's ROE is -0.39%, compared to APDN's ROE of -2.81%. Regarding short-term risk, ENZ is more volatile compared to APDN. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs ISPC Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, ISPC has a market cap of 2.3M. Regarding current trading prices, ENZ is priced at $0.31, while ISPC trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas ISPC's P/E ratio is -0.08. In terms of profitability, ENZ's ROE is -0.39%, compared to ISPC's ROE of -2.85%. Regarding short-term risk, ENZ is more volatile compared to ISPC. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs HTGM Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, HTGM has a market cap of 1.1M. Regarding current trading prices, ENZ is priced at $0.31, while HTGM trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas HTGM's P/E ratio is -0.03. In terms of profitability, ENZ's ROE is -0.39%, compared to HTGM's ROE of -2.73%. Regarding short-term risk, ENZ is more volatile compared to HTGM. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs BIOC Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, BIOC has a market cap of 450.8K. Regarding current trading prices, ENZ is priced at $0.31, while BIOC trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas BIOC's P/E ratio is -0.01. In terms of profitability, ENZ's ROE is -0.39%, compared to BIOC's ROE of -1.38%. Regarding short-term risk, ENZ is more volatile compared to BIOC. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs SQLLW Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, SQLLW has a market cap of 117.9K. Regarding current trading prices, ENZ is priced at $0.31, while SQLLW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas SQLLW's P/E ratio is -0.01. In terms of profitability, ENZ's ROE is -0.39%, compared to SQLLW's ROE of -19.68%. Regarding short-term risk, ENZ is more volatile compared to SQLLW. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs OCDX Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, OCDX has a market cap of 0. Regarding current trading prices, ENZ is priced at $0.31, while OCDX trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas OCDX's P/E ratio is -42.28. In terms of profitability, ENZ's ROE is -0.39%, compared to OCDX's ROE of +0.18%. Regarding short-term risk, ENZ is more volatile compared to OCDX. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.
ENZ vs MEUSW Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, MEUSW has a market cap of 0. Regarding current trading prices, ENZ is priced at $0.31, while MEUSW trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas MEUSW's P/E ratio is N/A. In terms of profitability, ENZ's ROE is -0.39%, compared to MEUSW's ROE of -3.10%. Regarding short-term risk, ENZ is less volatile compared to MEUSW. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.
ENZ vs DHR-PA Comparison
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, DHR-PA has a market cap of 0. Regarding current trading prices, ENZ is priced at $0.31, while DHR-PA trades at $1,841.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.24, whereas DHR-PA's P/E ratio is 233.57. In terms of profitability, ENZ's ROE is -0.39%, compared to DHR-PA's ROE of +0.07%. Regarding short-term risk, ENZ is more volatile compared to DHR-PA. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.